It was reported that patient underwent heart transplantation on (b)(6) 2024.The patient was elevated to status 3 due to driveline infection.Frist driveline infection was noted (b)(6) 2021 with staph aureus 2+.This was treated and cleared with oral antibiotics.On (b)(6) 2023, a new culture resulted with serratia marcescens 1+, staph aureus 1+, and pseudomonas aeruginosa which was treated with intravenous (iv) antibiotics.The patient's follow-up culture on (b)(6) 2023 was positive for gram negative rods and serratia marcescens 1+.They continued iv antibiotics.Then, follow-up wound culture on (b)(6) 2024 resulted with no growth.The device operated as expected.Driveline infection noted on (b)(6) 2023 is captured under mfr 2916596-2023-05853.Driveline infection on (b)(6) 2023 and (b)(6) 2023 is captured under mfr 2916596-2024-01852.
|